We selected tumor-infiltrating immune cell populations and defined them according to classical markers or evidence from the literature, including NK cells, CD4+ T cells, CD8+ T cells, myeloid cells, and B cells (Supplementary Fig. 3a–c). This evidence concerns the gene CD4 and neoplasm.